Aptose Biosciences is a clinical-stage biotechnology company advancing targeted agents to treat hematologic malignancies, including AML, MDS, CLL, and NHL.
Publicly Traded Company
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):